Complera (Rilpivirine + Emtricitabine + Tenofovir) - The Body

An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) - The Body

thebody.com — “ef-FAH-ver-enz / em-tri-SIT-uh-bean / te-NOE-fo-veer” View full resource at thebody.com

Most Recently Shared on August 17, 2011 at 10:01 pm By:

The Body Health Site

An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) http://t.co/4UjBvUf #hiv #aids #antiretrovirals #medications #combination

OrganizedWisdom HIV OW Health

Complera Once Daily Tablet For HIV-1 Infection Approved By FDA

medicalnewstoday.com — “Complera, (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naive adults (adults never treated before), h” View full resource at medicalnewstoday.com

Most Recently Shared on August 13, 2011 at 4:05 pm By:

Complera Once Daily Tablet For HIV-1 Infection Approved By FDA: Complera, (emtricitabine/rilpivirine/tenofovir d... http://t.co/EJ9zBjB

Trish D'Antonio Health Professional

Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination

fda.gov — “FDA approval of Approval of Complera, a new emtricitabine/rilpivirine/tenofovir DFfixed dose combination product for treatment of HIV” View full resource at fda.gov

Most Recently Shared on August 11, 2011 at 3:02 pm By:

HIV and AIDS Activities Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination: http://t.co/BVRnb2W

Complera Single-Tablet Regimen Approved for HIV-1 Infection in Treatment-Naïve Adults - MPR

empr.com — “The FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate; Gilead Sciences), a single-tablet regimen, for the treatment of HIV-1 infection in treatment-naïve adults.” View full resource at empr.com

Most Recently Shared on August 11, 2011 at 2:30 pm By:

MPR Medical Publisher

Complera Single-Tablet Regimen Approved for HIV-1 Infection in Treatment-Naïve Adults http://bit.ly/pCyTT8 #HIV #AIDS

MedicalFeed Health News Feed

Once-Daily Triple HIV Drug Receives FDA Approval - QualityPoint Technologies

qualitypointtech.net — “The FDA has granted approval of emtricitabine/rilpivirine/tenofovir (Complera), a once-daily, triple-drug combination treatment for treatment-naive patients with HIV. Medscape Medical News” View full resource at qualitypointtech.net

Most Recently Shared on August 11, 2011 at 3:00 am By:

Once-Daily Triple HIV Drug Receives FDA Approval: The FDA has granted approval of emtricitabine/rilpivirine/tenofo... http://bit.ly/ofsXA0

MedicalFeed Health News Feed

Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA - QualityPoint Technologies

qualitypointtech.net — “The US FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), a once-a-day single tablet for patients with HIV-1 infection who are new to treatment (treatment-naÃ¯ve patients), makers and marketers Gilead Sciences Inc. announced today. Complera contains three antiretroviral drugs in one tablet: Truvada - a Gilead medication, a fixed-dose combination of two medications, emtricitabine and tenofovir disoproxil fumarate. Approved by the FDA in August 2004...” View full resource at qualitypointtech.net

Most Recently Shared on August 11, 2011 at 1:45 am By:

Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA: The US FDA has approved Complera (emtricita... http://bit.ly/ozFQu6

Drugs and Devices OW OW Health

U.S. Food and Drug Administration Approves Gilead Sciences' Complera, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults

drugs.com — “Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is used to treat HIV infection. Includes Complera side effects, interactions and indications.” View full resource at drugs.com

Most Recently Shared on August 11, 2011 at 12:31 am By:

U.S. Food and Drug Administration Approves Gilead Sciences' Complera, a New Complete Once-Daily, Single-Ta... http://bit.ly/pFJ7v8 #drug